Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Value Investor Mohnish Pabrai Continues To Be Bullish On Horsehead Holding Corp. (ZINC)

Page 1 of 2

Mohnish Pabrai’s Dalal Street has acquired more shares of Horsehead Holding Corp. (NASDAQ:ZINC). In a Form 4 filing with the SEC, Dalal Street has disclosed purchases during the period of July 24 to July 28 of 470,653 shares in the manufacturer of zinc metal, at prices ranging from $7.82 to $8.12. After these transactions, Dalal Street holds an ownership stake of 7.48 million shares in Horsehead. The investment management firm acquired more shares of the company earlier this month, which might serve as an indicator that something good is expected to occur at Horsehead.


Dalal Street LLC is a value-driven hedge fund established by reputable investor Mohnish Pabrai in 1998. Dalal Street, where Pabrai currently acts as the managing partner, was launched with $1 million in assets under management and currently manages over $800 million in regulatory assets under management. The investing approach of Pabrai is believed to very much resemble Warren Buffett’s investing style. Unlike many of his peers in the industry who use mathematical models and gather massive amounts of data and information to make their investments, Pabrai takes on a particularly minimalist approach to stock investing. He is trying to stick to his circle of competence and aims at holding a concentrated portfolio of stocks in the businesses he understands. Dalal Street’s most recent 13F filing with the SEC reveals that the fund’s portfolio consists of only seven securities, which supports the idea that Pabrai prefers to invest in the businesses he understands and wait for returns rather than buy in and out of a high number of stocks. This gives the picks he does make great significance. The same filing indicates that Dalal Street manages a public equity portfolio worth $535.88 million.

Mohnish Pabrai
Mohnish Pabrai
Mohnish Pabrai

In the eyes of most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are more than 8,000 funds in operation at present, hedge fund experts at Insider Monkey look at the aristocrats of this group, around 700 funds. Contrary to popular belief Insider Monkey’s research revealed that hedge funds underperformed in recent years because of their short positions as well as the huge fees that they charge. Hedge funds managed to outperform the market on the long side of their portfolio. In fact, the 15 most popular small-cap stocks among hedge funds returned 123% since the end of August 2012 and beat the S&P 500 Index by 66 percentage points (see the details here). This is a huge margin which is why hedge funds’ recent Horsehead Holding Corp.  purchases is a strong indicator.

Horsehead Holding Corp. (NASDAQ:ZINC) is the parent company of Horsehead Corporation, which is the largest zinc producer in the United States and the leading manufacturer of value-added zinc products, which include zinc oxide and zinc powder. Horsehead Holding Corporation is also the parent company of International Metals Reclamation Company LLC, a leading recycler of metals-bearing wastes and a leading processor of nickel-cadmium batteries in North America; and Zochem Inc., a zinc oxide producer located in Brampton, Ontario. Horsehead Holding Corp. has seven facilities across the United States and Canada. The shares of Horsehead have dropped by over 48% since the beginning of the current year, mainly caused by reduced production as a result of various ramp-up issues at the Mooresboro, North Carolina facility. In this article we’ll discuss some updates on how the company has been attempting to solve its issues at the abovementioned facility.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!